Literature DB >> 19724682

Modeling glioma growth and invasion in Drosophila melanogaster.

Hanna Teresa Witte1, Astrid Jeibmann, Christian Klämbt, Werner Paulus.   

Abstract

Glioblastoma is the most common and most malignant intrinsic human brain tumor, characterized by extensive invasion and proliferation of glial (astrocytic) tumor cells, frequent activation of tyrosine kinase receptor signaling pathways, relative resistance to chemotherapy and radiotherapy, and poor prognosis. Using the Gal4-UAS system, we have produced glioma models in Drosophila by overexpressing homologs of human tyrosine kinase receptors under control of the glia-specific promoter reversed polarity (repo). Glial overexpression of activated epidermal growth factor receptor (EGFR) resulted in enhanced proliferation and migration of larval glial cells with increased numbers in the eye imaginal disc, diffuse tumor-like enlargement of the optic stalk, and marked ectopic invasion of glial cells along the optic nerve. Glial overexpression of the downstream kinase PI3K showed similar pathology. Overexpression of activated pvr (platelet-derived growth factor receptor/vascular endothelial growth factor receptor homolog) led to migration of glial cells along the optic nerve, whereas expression of activated htl (fibroblast growth factor receptor 1 homolog) and INR (insulin receptor) showed markedly elevated numbers of glial cells in the optic stalk. The EGFR/phosphatidylinositol 3-phosphate kinase (PI3K) phenotype was partly reverted by the administration of the EGFR tyrosine kinase inhibitor gefitinib and completely rescued by the PI3K inhibitor wortmannin and the Akt inhibitor triciribine. We suggest that Drosophila models will be useful for deciphering signaling cascades underlying abnormal behavior of glioma cells for genetic screens to reveal interacting genes involved in gliomagenesis and for experimental therapy approaches.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19724682      PMCID: PMC2735809          DOI: 10.1593/neo.09576

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  38 in total

Review 1.  Glial cell development in Drosophila.

Authors:  C Klämbt; T Hummel; S Granderath; K Schimmelpfeng
Journal:  Int J Dev Neurosci       Date:  2001-07       Impact factor: 2.457

2.  EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin.

Authors:  Anne Rappl; Guido Piontek; Jürgen Schlegel
Journal:  J Cell Sci       Date:  2008-11-25       Impact factor: 5.285

Review 3.  Gliomagenesis: genetic alterations and mouse models.

Authors:  E C Holland
Journal:  Nat Rev Genet       Date:  2001-02       Impact factor: 53.242

4.  The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation.

Authors:  N Tapon; N Ito; B J Dickson; J E Treisman; I K Hariharan
Journal:  Cell       Date:  2001-05-04       Impact factor: 41.582

Review 5.  Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomas.

Authors:  Warren P Mason; J Gregory Cairncross
Journal:  Neurology       Date:  2008-07-29       Impact factor: 9.910

6.  ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons.

Authors:  Patrick Oellers; Uwe Schröer; Volker Senner; Werner Paulus; Solon Thanos
Journal:  Glia       Date:  2009-04-01       Impact factor: 7.452

7.  Rethinking brain tumors: the fourth Mouse Models of Human Cancers Consortium nervous system tumors workshop.

Authors:  Karlyne M Reilly; Joshua B Rubin; Richard J Gilbertson; Joel R Garbow; Martine F Roussel; David H Gutmann
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

8.  Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity.

Authors:  Farnaz Yamoutpour; Vidya Bodempudi; Shay E Park; Weihong Pan; Mary Jean Mauzy; Robert A Kratzke; Arkadiusz Dudek; David A Potter; Richard A Woo; Donald M O'Rourke; Donald J Tindall; Faris Farassati
Journal:  Mol Cancer Ther       Date:  2008-11       Impact factor: 6.261

Review 9.  Drosophila melanogaster as a model organism of brain diseases.

Authors:  Astrid Jeibmann; Werner Paulus
Journal:  Int J Mol Sci       Date:  2009-02-02       Impact factor: 6.208

10.  A drosophila model for EGFR-Ras and PI3K-dependent human glioma.

Authors:  Renee D Read; Webster K Cavenee; Frank B Furnari; John B Thomas
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

View more
  39 in total

1.  miR-285-Yki/Mask double-negative feedback loop mediates blood-brain barrier integrity in Drosophila.

Authors:  Dong Li; Yanling Liu; Chunli Pei; Peng Zhang; Linqing Pan; Jing Xiao; Songshu Meng; Zengqiang Yuan; Xiaolin Bi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

2.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

3.  In vivo analysis of compound activity and mechanism of action using epistasis in Drosophila.

Authors:  Erdem Bangi; Dan Garza; Marc Hild
Journal:  J Chem Biol       Date:  2010-12-22

4.  Linking model systems to cancer therapeutics: the case of Mastermind.

Authors:  Barry Yedvobnick; Ken Moberg
Journal:  Dis Model Mech       Date:  2010-07-27       Impact factor: 5.758

5.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

Review 6.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

7.  Pvr receptor tyrosine kinase signaling promotes post-embryonic morphogenesis, and survival of glia and neural progenitor cells in Drosophila.

Authors:  Renee D Read
Journal:  Development       Date:  2018-12-04       Impact factor: 6.868

Review 8.  Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics.

Authors:  Cayetano Gonzalez
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

9.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 10.  Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies.

Authors:  Leon Chen; Yuqing Zhang; Jingxuan Yang; John P Hagan; Min Li
Journal:  Biochim Biophys Acta       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.